We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+19.73%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$204B
AUM Growth
+$40.7B
Cap. Flow
+$14.4B
Cap. Flow %
7.02%
Top 10 Hldgs %
15.11%
Holding
4,579
New
569
Increased
2,381
Reduced
1,060
Closed
261

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$845M
2
TME icon
Tencent Music
TME
+$643M
3
BIDU icon
Baidu
BIDU
+$528M
4
TSLA icon
Tesla
TSLA
+$476M
5
AMZN icon
Amazon
AMZN
+$391M

Sector Composition

Rank Sector Weight
1 Technology 13.51%
2 Consumer Discretionary 9.39%
3 Healthcare 9.23%
4 Communication Services 7.28%
5 Financials 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QS icon
3476
QuantumScape Corp
QS
$3.74B
$727K ﹤0.01%
8,611
-233,046
-96% -$8.53M
BMTC
3477
DELISTED
Bryn Mawr Bank Corp
BMTC
$727K ﹤0.01%
23,754
+6,215
+35% +$182K
BV icon
3478
BrightView Holdings
BV
$1.07B
$726K ﹤0.01%
48,045
+13,501
+39% +$185K
LOCO icon
3479
El Pollo Loco
LOCO
$462M
$726K ﹤0.01%
40,108
+3,108
+8% +$52.2K
CASS icon
3480
Cass Information Systems
CASS
$743M
$725K ﹤0.01%
18,644
+5,666
+44% +$236K
SP
3481
DELISTED
SP Plus Corporation
SP
$725K ﹤0.01%
25,093
+9,506
+61% +$233K
EARN
3482
Ellington Residential Mortgage REIT
EARN
$165M
$723K ﹤0.01%
55,458
+11,302
+26% +$133K
ORIC icon
3483
Oric Pharmaceuticals
ORIC
$1.4B
$722K ﹤0.01%
+21,322
New +$612K
ATEC icon
3484
Alphatec Holdings
ATEC
$1.44B
$720K ﹤0.01%
+49,561
New +$523K
ASND icon
3485
Ascendis Pharma A/S
ASND
$16.8B
$719K ﹤0.01%
4,310
-89
-2% -$14.7K
TRV icon
3486
PUT
Travelers Companies
TRV
$80.2B
$716K ﹤0.01%
5,100
SI
3487
DELISTED
Silvergate Capital Corporation
SI
$715K ﹤0.01%
+9,625
New +$317K
HNGR
3488
DELISTED
Hanger Inc.
HNGR
$715K ﹤0.01%
32,478
+13,012
+67% +$267K
WCN
3489
Waste Connections
WCN
$42B
$714K ﹤0.01%
6,961
-8,697
-56% -$898K
ALBO
3490
DELISTED
Albireo Pharma Inc
ALBO
$711K ﹤0.01%
+18,929
New +$688K
CTMX icon
3491
CytomX Therapeutics
CTMX
$754M
$709K ﹤0.01%
108,176
-30,411
-22% -$217K
NXE icon
3492
NexGen Energy
NXE
$6.99B
$709K ﹤0.01%
256,791
+45,157
+21% +$90.5K
ADTN icon
3493
Adtran
ADTN
$616M
$708K ﹤0.01%
47,871
+16,133
+51% +$205K
AES icon
3494
CALL
AES
AES
$10.5B
$707K ﹤0.01%
30,100
-44,900
-60% -$933K
HTBK
3495
DELISTED
Heritage Commerce
HTBK
$707K ﹤0.01%
79,860
+18,669
+31% +$151K
FRTA
3496
DELISTED
Forterra, Inc
FRTA
$707K ﹤0.01%
41,167
+27,380
+199% +$438K
JETS icon
3497
CALL
US Global Jets ETF
JETS
$800M
$705K ﹤0.01%
+31,500
New +$635K
COWN
3498
DELISTED
Cowen Inc. Class A Common Stock
COWN
$704K ﹤0.01%
27,056
+10,514
+64% +$237K
DDG
3499
DELISTED
Proshares Short Oil & Gas
DDG
$704K ﹤0.01%
27,601
+11,650
+73% +$347K
SLG icon
3500
PUT
SL Green Realty
SLG
$3.99B
$703K ﹤0.01%
+11,465
New +$606K

Similar funds

Credit Suisse's Q4 2020 Portfolio in Review

As of Q4 2020, Credit Suisse held 4,579 positions worth $204B, up 25% from $164B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $14.4B of net new capital in Q4 2020, opening 569 new positions and adding to 2,381 existing holdings. Its largest new stake was Palantir: 6,341,206 shares worth $149M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was UnitedHealth, an estimated $546M trimmed.

  • Credit Suisse's largest Q4 2020 buy was Palantir: 6,341,206 shares worth $149M.
  • Credit Suisse added most to Alibaba in Q4 2020, an estimated $845M increase.
  • Credit Suisse's biggest Q4 2020 reduction was UnitedHealth, cutting an estimated $546M.
  • Credit Suisse fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $260M.
  • Credit Suisse's ten largest holdings make up 15% of its $204B portfolio in Q4 2020.
  • Credit Suisse opened 569 new positions and closed 261 in Q4 2020.
  • Credit Suisse's portfolio value rose 25% quarter-over-quarter to $204B.

Based on Credit Suisse's 13F filing for Q4 2020, filed 12 Feb 2021.